Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 6Sarcoma 3Endocrine 2Thoracic 1NET 1Gynecologic 1Genitourinary 1Dermatologic 1

Conditions

Neuroendocrine Tumors 73Carcinoma, Neuroendocrine 27Pheochromocytoma 24Thyroid Cancer, Papillary 23Thyroid Neoplasms 21Pituitary Neoplasms 21Adrenocortical Carcinoma 19Paraganglioma 16Multiple Endocrine Neoplasia Type 1 14Neuroblastoma 12Sarcoma 11Adenoma, Islet Cell 11Small Cell Lung Carcinoma 10Neoplasms 10Melanoma 10Lung Neoplasms 9Carcinoid Tumor 9Adrenal Gland Neoplasms 9Adenocarcinoma, Follicular 9Pancreatic Neoplasms 8Gastro-enteropancreatic neuroendocrine tumor 8Carcinoma, Non-Small-Cell Lung 8Carcinoma, Medullary 8Thyroid Carcinoma, Anaplastic 7Neoplasm Metastasis 7Mesothelioma 7Cushing Syndrome 7Cholangiocarcinoma 7Central Nervous System Neoplasms 7Breast Neoplasms 7

Interventions

olaparib 1lutetium Lu 177 dotatate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Esthesioneuroblastoma, Olfactory × Endocrine × 90 days × Clear all
NCT06607692 2026-06-04

LUPARPED

Fundación de investigación HM

Phase 1/2 Recruiting
25 enrolled
CNSEndocrineNETSarcoma

Adrenal Cortex Neoplasms, Adrenal Gland Neoplasms, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neuroblastoma, Paraganglioma, Pheochromocytoma, Recurrence, Osteosarcoma, Sarcoma, Synovial, Esthesioneuroblastoma, Olfactory, Neuroendocrine Tumors

NCT04087902 2026-05-20

Long-Term Longitudinal QoL in Patients Undergoing EEA

Ohio State University

Active not recruiting
400 enrolled
CNSEndocrineSarcoma

Chondrosarcoma, Chordoma, Craniopharyngioma, Encephalocele, Meningioma, Pituitary Neoplasms, Esthesioneuroblastoma, Olfactory, Central Nervous System Cysts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡